scholarly article | Q13442814 |
P50 | author | Sylvain Doré | Q57047750 |
P2093 | author name string | Sean Robbins | |
Christopher C Leonardo | |||
P2860 | cites work | Describing functioning, disability, and health with the International Classification of Functioning, Disability, and Health Brief Core Set for Stroke. | Q50976891 |
Elevated serum S100B levels indicate a higher risk of hemorrhagic transformation after thrombolytic therapy in acute stroke. | Q51743594 | ||
Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. | Q52047529 | ||
Postthrombolysis Blood Pressure Elevation Is Associated With Hemorrhagic Transformation | Q58209315 | ||
Comparison of brain cell death and inflammatory reaction in three models of intracerebral hemorrhage in adult rats | Q58856658 | ||
Intracerebral injection of autologous whole blood in rats: time course of inflammation and cell death | Q58856662 | ||
Clinical usefulness of the semiquantitative procalcitonin test in the diagnosis of bacterial infections in a third level children's hospital | Q59712319 | ||
Time window for clinical effectiveness of mass evacuation in a rat balloon model mimicking an intraparenchymatous hematoma | Q73515885 | ||
Intracortical hemorrhage injury in rats : relationship between blood fractions and brain cell death | Q73964325 | ||
Lysis of intracerebral hematoma with stereotactically implanted tissue plasminogen activator polymers in a rabbit model | Q80231934 | ||
Intracerebral hemorrhage models in rat: comparing collagenase to blood infusion | Q80861082 | ||
Hematoma growth in oral anticoagulant related intracerebral hemorrhage | Q81785203 | ||
Gauging recovery after hemorrhagic stroke in rats: implications for cytoprotection studies | Q82182161 | ||
Cerebral arteriovenous malformations | Q82250897 | ||
Diagnostic accuracy of plasma glial fibrillary acidic protein for differentiating intracerebral hemorrhage and cerebral ischemia in patients with symptoms of acute stroke | Q82720746 | ||
Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study | Q35558386 | ||
Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons. | Q35745836 | ||
PGE2 EP1 receptor exacerbated neurotoxicity in a mouse model of cerebral ischemia and Alzheimer's disease. | Q35823015 | ||
A critical appraisal of experimental intracerebral hemorrhage research | Q35866886 | ||
Hyperglycemia promotes tissue plasminogen activator-induced hemorrhage by Increasing superoxide production | Q36010304 | ||
Priorities for clinical research in intracerebral hemorrhage: report from a National Institute of Neurological Disorders and Stroke workshop | Q36030319 | ||
Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke | Q36142617 | ||
Intracerebral hemorrhage associated with oral anticoagulant therapy: current practices and unresolved questions | Q36336888 | ||
Mechanisms of brain injury after intracerebral haemorrhage. | Q36345249 | ||
Inflammation after intracerebral hemorrhage | Q36620460 | ||
Experimental intracerebral hemorrhage: relationship between brain edema, blood flow, and blood-brain barrier permeability in rats | Q36752639 | ||
Experimental model of warfarin-associated intracerebral hemorrhage | Q37017480 | ||
Repairing the human brain after stroke: I. Mechanisms of spontaneous recovery | Q37126181 | ||
Admission hyperglycemia predicts a worse outcome in stroke patients treated with intravenous thrombolysis | Q37139530 | ||
Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy. | Q37180410 | ||
Blood biomarkers in the diagnosis of ischemic stroke: a systematic review | Q37227913 | ||
Beta-amyloid, blood vessels, and brain function | Q37246552 | ||
Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention | Q37316677 | ||
Mechanisms and markers for hemorrhagic transformation after stroke. | Q37344473 | ||
Genetic animal models of cerebral vasculopathies | Q37542635 | ||
Invited article: searching for oracles? Blood biomarkers in acute stroke. | Q37571237 | ||
Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management | Q37692824 | ||
Rodent models of intracerebral hemorrhage. | Q37793695 | ||
Strategies for assessment and outcome measurement in physical and rehabilitation medicine: an educational review | Q37891835 | ||
Natural course of perihemorrhagic edema after intracerebral hemorrhage. | Q37898918 | ||
Is the spontaneously hypertensive stroke prone rat a pertinent model of sub cortical ischemic stroke? A systematic review | Q37939375 | ||
Challenges and controversies in the medical management of primary and antithrombotic-related intracerebral hemorrhage | Q37978627 | ||
Do current animal models of intracerebral hemorrhage mirror the human pathology? | Q38170028 | ||
Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage | Q40518629 | ||
Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. | Q40607050 | ||
Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products | Q42170839 | ||
Erythrocytes and delayed brain edema formation following intracerebral hemorrhage in rats | Q42464660 | ||
Collagenase-induced intracerebral hemorrhage in rats | Q42479802 | ||
Absence of early proinflammatory cytokine expression in experimental intracerebral hemorrhage | Q42508600 | ||
Experimental intracerebral hemorrhage in rats. Magnetic resonance imaging and histopathological correlates | Q42551811 | ||
Asymptomatic hemorrhagic transformation of infarction and its relationship with functional outcome and stroke subtype: assessment from the Tinzaparin in Acute Ischaemic Stroke Trial | Q42844275 | ||
Long-term histological and behavioural characterisation of a collagenase-induced model of intracerebral haemorrhage in rats | Q42988685 | ||
Effects of perindopril-based lowering of blood pressure on intracerebral hemorrhage related to amyloid angiopathy: the PROGRESS trial | Q43203769 | ||
Age-dependent lethality in novel transgenic mouse models of central nervous system arteriovenous malformations | Q44235352 | ||
Safety and outcomes following thrombolytic treatment in stroke patients who had received prior treatment with anticoagulants | Q44442729 | ||
Long-term prognosis after recovery from primary intracerebral hemorrhage | Q44997592 | ||
Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage | Q45081496 | ||
Spontaneous stroke in a genetic model of hypertension in mice | Q46508463 | ||
Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes | Q46640803 | ||
Long-term effects of experimental intracerebral hemorrhage: the role of iron | Q46969940 | ||
Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke. | Q47421490 | ||
Subarachnoid hemorrhage model in the rat: modification of the endovascular filament model | Q47628992 | ||
Inflammatory responses in the rat brain in response to different methods of intra-cerebral administration | Q47979823 | ||
Apolipoprotein E markedly facilitates age-dependent cerebral amyloid angiopathy and spontaneous hemorrhage in amyloid precursor protein transgenic mice. | Q48215367 | ||
Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury | Q48233639 | ||
Cerebral amyloid angiopathy in the elderly: vessel walls changes and relationship with dementia | Q48235883 | ||
Neuropsychological impairment after hemorrhagic stroke in basal ganglia | Q48254360 | ||
Early hemodynamic changes in experimental intracerebral hemorrhage | Q48280640 | ||
Assessing cognitive function after intracerebral hemorrhage in rats. | Q48312156 | ||
Behavioral tests after intracerebral hemorrhage in the rat. | Q48475050 | ||
CT and diffusion-weighted MR imaging in randomized order: diffusion-weighted imaging results in higher accuracy and lower interrater variability in the diagnosis of hyperacute ischemic stroke | Q48491602 | ||
Comparison of experimental rat models of early brain injury after subarachnoid hemorrhage | Q48510631 | ||
Determination of serum visinin like protein-1 and its potential for the diagnosis of brain injury due to the stroke: a pilot study. | Q48686212 | ||
Stroke: Brain natriuretic peptide could be a biomarker for outcomes after cardioembolic stroke | Q48695759 | ||
Plasma β-amyloid levels in cerebral amyloid angiopathy-associated hemorrhagic stroke. | Q48702297 | ||
Pentraxin 3: a novel and independent prognostic marker in ischemic stroke. | Q48770462 | ||
Characterisation of the diagnostic window of serum glial fibrillary acidic protein for the differentiation of intracerebral haemorrhage and ischaemic stroke | Q48822422 | ||
Therapeutic benefit of urocortin in rats with intracerebral hemorrhage | Q48857061 | ||
Glial responses, neuron death and lesion resolution after intracerebral hemorrhage in young vs. aged rats. | Q48857393 | ||
Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy. | Q48974670 | ||
Lobar intracerebral hemorrhage model in pigs: rapid edema development in perihematomal white matter | Q49105220 | ||
Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy | Q49409019 | ||
Preclinical and clinical research on inflammation after intracerebral hemorrhage | Q24594191 | ||
Cerebral microinfarcts: the invisible lesions | Q27026027 | ||
Guidelines for the Early Management of Adults With Ischemic Stroke | Q28297859 | ||
Structural and functional disruption of vascular smooth muscle cells in a transgenic mouse model of amyloid angiopathy | Q28359737 | ||
Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases | Q28580357 | ||
Heart disease and stroke statistics--2012 update: a report from the American Heart Association | Q29547909 | ||
Update of the stroke therapy academic industry roundtable preclinical recommendations | Q29615508 | ||
1,026 experimental treatments in acute stroke | Q29615509 | ||
Analysis of cerebral amyloid angiopathy in a transgenic mouse model of Alzheimer disease using in vivo multiphoton microscopy | Q30658000 | ||
Intracerebral haemorrhage | Q33442365 | ||
Initial CT findings in 753 patients with severe head injury. A report from the NIH Traumatic Coma Data Bank | Q33454197 | ||
Neuroprotective role of haptoglobin after intracerebral hemorrhage | Q33699650 | ||
Recommendations for standards regarding preclinical neuroprotective and restorative drug development | Q33785562 | ||
A rat model of studying tissue-type plasminogen activator thrombolysis in ischemic stroke with diabetes | Q34066733 | ||
Cerebral amyloid angiopathy in the elderly | Q34108298 | ||
Traumatic subarachnoid hemorrhage: demographic and clinical study of 750 patients from the European brain injury consortium survey of head injuries. | Q34114024 | ||
αII-spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients | Q34142573 | ||
Aging and cerebrovascular dysfunction: contribution of hypertension, cerebral amyloid angiopathy, and immunotherapy | Q34219814 | ||
Recommendations for clinical trial evaluation of acute stroke therapies. | Q34300670 | ||
Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. | Q34341174 | ||
Tuftsin fragment 1-3 is beneficial when delivered after the induction of intracerebral hemorrhage. | Q34391036 | ||
Hyperglycemia-induced cerebral hematoma expansion is mediated by plasma kallikrein | Q34572652 | ||
Blood-based diagnostics of traumatic brain injuries | Q34714369 | ||
The development of an improved preclinical mouse model of intracerebral hemorrhage using double infusion of autologous whole blood | Q34789898 | ||
Brain injury after intracerebral hemorrhage in spontaneously hypertensive rats. | Q35022280 | ||
White matter damage and the effect of matrix metalloproteinases in type 2 diabetic mice after stroke | Q35025916 | ||
Biokinetic analysis of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in severe traumatic brain injury patient biofluids | Q35040539 | ||
Molecular pathophysiology of cerebral hemorrhage: secondary brain injury | Q35070264 | ||
Caspase-mediated cleavage of glial fibrillary acidic protein within degenerating astrocytes of the Alzheimer's disease brain | Q35088000 | ||
Blocking the apolipoprotein E/amyloid-β interaction reduces fibrillar vascular amyloid deposition and cerebral microhemorrhages in TgSwDI mice | Q35095392 | ||
Experimental intracerebral hemorrhage: avoiding pitfalls in translational research | Q35534164 | ||
P304 | page(s) | 85 | |
P577 | publication date | 2012-05-29 | |
P1433 | published in | Frontiers in Neurology | Q15817039 |
P1476 | title | Translating basic science research to clinical application: models and strategies for intracerebral hemorrhage | |
P478 | volume | 3 |
Q55019304 | A Comparison of Pathophysiology in Humans and Rodent Models of Subarachnoid Hemorrhage. |
Q35389143 | Experimental subarachnoid hemorrhage in rats: comparison of two endovascular perforation techniques with respect to success rate, confounding pathologies and early hippocampal tissue lesion pattern |
Q37420266 | Fast neuroprotection (fast-NPRX) for acute ischemic stroke victims: the time for treatment is now. |
Q26865843 | Intracerebral hemorrhage in mouse models: therapeutic interventions and functional recovery |
Q35123058 | The relationship between the serum levels of ferritin and the radiological brain injury indices in patients with spontaneous intracerebral hemorrhage |
Q52597283 | Uncovering the Rosetta Stone: Report from the First Annual Conference on Key Elements in Translating Stroke Therapeutics from Pre-Clinical to Clinical. |
Search more.